CureVac NV CVAC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
3.03UNCH (UNCH)
Volume
1,397
Close
3.03quote price arrow down-0.02 (-0.66%)
Volume
409,967
52 week range
2.76 - 12.36
Loading...
  • Open3.08
  • Day High3.19
  • Day Low3.01
  • Prev Close3.05
  • 52 Week High12.36
  • 52 Week High Date06/23/23
  • 52 Week Low2.76
  • 52 Week Low Date03/20/24

Key Stats

  • Market Cap678.489M
  • Shares Out223.92M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta2.51
  • YTD % Change-28.03

KEY STATS

  • Open3.08
  • Day High3.19
  • Day Low3.01
  • Prev Close3.05
  • 52 Week High12.36
  • 52 Week High Date06/23/23
  • 52 Week Low2.76
  • 52 Week Low Date03/20/24
  • Market Cap678.489M
  • Shares Out223.92M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta2.51
  • YTD % Change-28.03

RATIOS/PROFITABILITY

  • EPS (TTM)-1.47
  • P/E (TTM)-2.07
  • Fwd P/E (NTM)-3.99
  • EBITDA (TTM)-311.833M
  • ROE (TTM)-49.26%
  • Revenue (TTM)46.422M
  • Gross Margin (TTM)-251.61%
  • Net Margin (TTM)-704.99%
  • Debt To Equity (MRQ)6.99%

EVENTS

  • Earnings Date04/23/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CureVac NV

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Malte Greune Ph.D.
Chief Operating Officer, Member of the Management Board
Pierre Kemula
Chief Financial Officer, Member of the Management Board
Address
Friedrich-Miescher-Str. 15
Tuebingen
72076
Germany

Top Peers

SYMBOLLASTCHG%CHG
OABI
OmniAb Inc
5.42+0.03+0.56%
MRSN
Mersana Therapeutics Inc
4.48-0.01-0.22%
EXAI
Exscientia PLC
5.72-0.06-1.04%
FATE
Fate Therapeutics Inc
7.34UNCHUNCH
TNGX
Tango Therapeutics Inc
7.94+0.24+3.12%